The C1 and C2 Domains of Protein Kinase C Are Independent Membrane Targeting Modules, with Specificity for Phosphatidylserine Conferred by the C1 Domain†

Biochemistry ◽  
2000 ◽  
Vol 39 (37) ◽  
pp. 11360-11369 ◽  
Author(s):  
Joanne E. Johnson ◽  
Jennifer Giorgione ◽  
Alexandra C. Newton
2012 ◽  
Vol 165 (3) ◽  
pp. 320-330 ◽  
Author(s):  
Narsimha Mamidi ◽  
Sukhamoy Gorai ◽  
Jashobanta Sahoo ◽  
Debasis Manna

2000 ◽  
Vol 275 (8) ◽  
pp. 6014-6021 ◽  
Author(s):  
Alice Vallentin ◽  
Corinne Prévostel ◽  
Teddy Fauquier ◽  
Xavier Bonnefont ◽  
Dominique Joubert

Biochemistry ◽  
2001 ◽  
Vol 40 (34) ◽  
pp. 10334-10341 ◽  
Author(s):  
Cojen Ho ◽  
Simon J. Slater ◽  
Brigid Stagliano ◽  
Christopher D. Stubbs

1994 ◽  
Vol 299 (3) ◽  
pp. 853-861 ◽  
Author(s):  
K Robinson ◽  
D Jones ◽  
Y Patel ◽  
H Martin ◽  
J Madrazo ◽  
...  

The ability of individual members of the 14-3-3 protein family to inhibit protein kinase C (PKC) has been studied by using a synthetic peptide based on the specific 80 kDa substrate for PKC (MARCKS protein) in two different assay systems. Recombinant 14-3-3 and isoforms renatured by a novel method after separation by reverse-phase h.p.l.c. were studied. The detailed effects of diacylglycerol and the phorbol ester phorbol 12-myristate 13-acetate on the inhibition were also investigated. This suggests that one of the sites of interaction of 14-3-3 may be the cysteine-rich (C1) domain in PKC. Since a region in secreted phospholipase A2 (PLA2) shares similarity with this domain, the ability of 14-3-3 to interact with mammalian PLA2 was studied. Cytosolic PLA2 has some similarity to the C2 region of PKC, and the effect of 14-3-3 on this class of PLA2 was also analysed. In contrast with a previous report, no PLA2 activity was found in brain 14-3-3, nor in any of the recombinant proteins tested. These include zeta 14-3-3 isoform, on which the original observation was made.


2014 ◽  
Vol 10 (11) ◽  
pp. 3002-3013 ◽  
Author(s):  
Narsimha Mamidi ◽  
Subhankar Panda ◽  
Rituparna Borah ◽  
Debasis Manna

Protein kinase C-C1 domain binding specificity of the anionic hybrid lipids.


FEBS Letters ◽  
1991 ◽  
Vol 285 (1) ◽  
pp. 120-123 ◽  
Author(s):  
James P. Sullivan ◽  
Jane R. Connor ◽  
Carol Tiffany ◽  
Barry G. Shearer ◽  
Ronald M. Burch

1997 ◽  
Vol 8 (10) ◽  
pp. 1889-1899 ◽  
Author(s):  
Meirav Matto-Yelin ◽  
Alastair Aitken ◽  
Shoshana Ravid

Myosin II heavy chain (MHC) specific protein kinase C (MHC-PKC), isolated from Dictyostelium discoideum, regulates myosin II assembly and localization in response to the chemoattractant cyclic AMP. Immunoprecipitation of MHC-PKC revealed that it resides as a complex with several proteins. We show herein that one of these proteins is a homologue of the 14–3-3 protein (Dd14–3-3). This protein has recently been implicated in the regulation of intracellular signaling pathways via its interaction with several signaling proteins, such as PKC and Raf-1 kinase. We demonstrate that the mammalian 14–3-3 ζ isoform inhibits the MHC-PKC activity in vitro and that this inhibition is carried out by a direct interaction between the two proteins. Furthermore, we found that the cytosolic MHC-PKC, which is inactive, formed a complex with Dd14–3-3 in the cytosol in a cyclic AMP-dependent manner, whereas the membrane-bound active MHC-PKC was not found in a complex with Dd14–3-3. This suggests that Dd14–3-3 inhibits the MHC-PKC in vivo. We further show that MHC-PKC binds Dd14–3-3 as well as 14–3-3ζ through its C1 domain, and the interaction between these two proteins does not involve a peptide containing phosphoserine as was found for Raf-1 kinase. Our experiments thus show an in vivo function for a member of the 14–3-3 family and demonstrate that MHC-PKC interacts directly with Dd14–3-3 and 14–3-3ζ through its C1 domain both in vitro and in vivo, resulting in the inhibition of the kinase.


Sign in / Sign up

Export Citation Format

Share Document